Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | METAP2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | PSMB6 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | LSM10 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | SHCBP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | KCNN3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | EIF5A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | CCDC102A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | NUGGC | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |